CONSORT 2025 statement: updated guideline for reporting randomised trialsOPEN ACCESS
BMJ · DOI: 10.1136/bmj-2024-081123
2025
BMJ · 28 August 2019
Describes the revised Cochrane tool for judging risk of bias in the results of randomised trials. Bias is assessed across five domains using signalling questions and an algorithm, giving reviewers a more structured and transparent basis for their judgements than the original tool.
Summary written by Sterling IMRES editors. Read the original abstract at the publisher.
The full author list is available from the publisher.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;l4898. doi:10.1136/bmj.l4898
BMJ · DOI: 10.1136/bmj-2024-081123
BMJ · DOI: 10.1136/bmj.j4008